Concerning the tremendous value of co‐signaling molecules in anti‐tumor therapy, and to better understand this issue, we conducted this case‐control study to clarify the detailed relationship of four tagging BTLA polymorphisms with the risk of ESCC in the eastern Chinese Han population. This evidence concerns the gene BTLA and esophageal squamous cell carcinoma.